Stock Events

Stock Events

Axonex AI Group 

$0.9885
16
+$0.06+6.15%Wednesday 21:00
+$0.00+0%00:30After hours

Statistics

Day High
1.03
Day Low
1.03
52W High
37.25
52W Low
0.68
Volume
236
Avg. Volume
-
Mkt Cap
5.85M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Mar 5Expected
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-0.38
-0.17
0.04
0.25
Expected EPS
0.24625
Actual EPS
N/A

Financials

0.1%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
476.11MRevenue
486,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AXNX. It's not an investment recommendation.
Realty Income
4
O
Tesla
4
TSLA
AMD
4
AMD
Cameco
4
CCJ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap123.49B
Medtronic is a major competitor in the neuromodulation market, offering products that directly compete with Axonics' sacral neuromodulation devices for bladder and bowel control.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific competes in the neuromodulation space, particularly in pelvic health solutions, which overlaps with Axonics' product offerings.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie, through its acquisition of Allergan, owns Latisse, which competes in the broader neuromodulation and urology markets relevant to Axonics' interests.
Novo Nordisk
NVO
Mkt Cap176.43B
Novo Nordisk competes indirectly through their treatments for conditions like diabetes, which can have urological complications that products from Axonics aim to address.
Pfizer
PFE
Mkt Cap173.95B
Pfizer offers products in the urology segment, including treatments for overactive bladder, which is a condition Axonics' devices aim to treat.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its medical devices division, offers products that can be used in surgical procedures related to urology and pelvic health, competing with Axonics.
Smith & Nephew
SNN
Mkt Cap12.43B
Smith & Nephew, while primarily focused on orthopedics, has products in the wound care space that could indirectly compete with Axonics in post-operative care for pelvic health procedures.
Stryker
SYK
Mkt Cap111.95B
Stryker operates in the medical technology field with a broad portfolio that could compete with Axonics in surgical equipment and devices for urology and neuromodulation procedures.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet, mainly focused on orthopedics, has been expanding into new areas, including minimally invasive therapies that could compete with Axonics' neuromodulation devices.
Edwards Lifesciences
EW
Mkt Cap53.03B
Edwards Lifesciences, known for heart valves, also explores areas in medical technologies that could intersect with Axonics' focus on neuromodulation and pelvic health.

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Axonex AI Group Ltd is a Hong Kong-based company strategically focused on artificial intelligence (AI) and robotics, and an established business interior design and fit-out works provider. Through its subsidiary, Axonex AI Limited, and its majority-owned subsidiary, Rice Robotics AGI Holding Limited, the Group delivers robot models and robotics solutions, including the FLOKI Minibot M1 and micro-insurance solutions purpose-built for commercial robots. The Group also maintains its established interior design and fit-out works business. Anchored by its ongoing transformation, Axonex AI is focused on AI and robotics as its main growth-driving engine.
Show More
CEO
Hoi Lung Chan
Employees
16
Country
Hong Kong
ISIN
VGG6146G1256
WKN
000A2N7B2

Listings

STU
DE
0I3.STU
XNAS
US
AXNX

0 Comments

Share your thoughts

FAQs

What is Axonex AI Group stock price today?▼
The current price of AXNX is $0.99 USD — it has increased by +6.15% in the past 24 hours. Watch Axonex AI Group stock price performance more closely on the chart.
What is Axonex AI Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Axonex AI Group stocks are traded under the ticker AXNX.
Is Axonex AI Group stock price growing?▼
AXNX stock has fallen by -4.03% compared to the previous week, the month change is a -54.34% fall, over the last year Axonex AI Group has showed a -91.4% decrease.
What is Axonex AI Group market cap?▼
Today Axonex AI Group has the market capitalization of 5.85M
What is Axonex AI Group revenue for the last year?▼
Axonex AI Group revenue for the last year amounts to 476.11M USD.
What is Axonex AI Group net income for the last year?▼
AXNX net income for the last year is 486,000 USD.
How many employees does Axonex AI Group have?▼
As of November 5, 2026, the company has 16 employees.
In which sector is Axonex AI Group located?▼
Axonex AI Group operates in the Manufacturing sector.
When did Axonex AI Group complete a stock split?▼
The last stock split for Axonex AI Group was on October 22, 2026 with a ratio of 2:5.
Where is Axonex AI Group headquartered?▼
Axonex AI Group is headquartered in Hong Kong, Hong Kong.